IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login 
Users Online : 3849 
Small font sizeDefault font sizeIncrease font size
Navigate Here
 ╗   Next article
 ╗   Previous article
 ╗   Table of Contents

Resource Links
 ╗   Similar in PUBMED
 ╗  Search Pubmed for
 ╗  Search in Google Scholar for
 ╗Related articles
 ╗   Citation Manager
 ╗   Access Statistics
 ╗   Reader Comments
 ╗   Email Alert *
 ╗   Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed1688    
    Printed92    
    Emailed0    
    PDF Downloaded121    
    Comments [Add]    

Recommend this journal

 

 RESEARCH PAPER
Year : 1996  |  Volume : 28  |  Issue : 3  |  Page : 181-184

Evaluation of clinical efficacy and safety of hydroxyethyl starch



Correspondence Address:
Rani P Usha


Login to access the Email id

Source of Support: None, Conflict of Interest: None


Rights and PermissionsRights and Permissions

Hydroxyethyl starch (HES) 6% has been shown to improve hypovolaemia, with minimum side effects and long duration of action. Thirty patients showing signs of hypovolaemia post-operatively, in the form of tachycardia and hypotension received 500 ml of 6% HES intravenously over 30-60 minutes. Administration of HES, significantly improved hypovolaemia in all the patients. Within 30 minutes after infusion, systolic blood pressure (SBP) increased from 85˝ 6 to 98˝ 8 mm Hg. Heart rate decreased from 124˝ 3 beats per minute (bpm) to 99˝ 6 bpm and central venous pressure (CVP) increased from 1˝ 1 to 3.5k1.2 cm of saline, at one hour post HES administration. This improvement persisted till the end of sixth hour observation period. All patients tolerated HES well without any side effects and hematological or biochemical abnormalities.






[PDF]*


        
Print this article     Email this article

Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer
Online since 20th July '04
Published by Wolters Kluwer - Medknow